Ignite Creation Date:
2024-05-06 @ 2:48 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04426994
Status:
COMPLETED
Last Update Posted:
2020-06-11
First Post:
2020-06-08
Brief Title:
Hypomagnesemia Associated With Proton-Pump Inhibitor Use
Sponsor:
Changi General Hospital
Organization:
Changi General Hospital
Study Overview
Official Title:
Hypomagnesemia Associated With Proton-Pump Inhibitor Use
Status:
COMPLETED
Status Verified Date:
2020-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PPI_HypoMg
Brief Summary:
Use of proton pump inhibitors has been associated with hypomagnesemia However various case-control or prospective studies have found conflicting results with regards to proton pump inhibitors use and development of hypomagnesemia Our aim was to evaluate the likelihood that proton pump inhibitors contributed to severe hypomagnesemia in a retrospective cohort of patients admitted with severe hypomagenesemia We also aimed to look for risk factors leading to development of hypomagnesemia amongst users of proton pump inhibitors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None